Therefore, in the future, a more extensive prospective study is needed, including a large number of participants equally represented across all CAD stages, with monitoring of Lp-PLA2 concentrations to obtain a clearer picture, particularly regarding the critical Lp-PLA2 value in patients in the early stages of CAD and those with T2DM who have no CAD symptoms and/or have not undergone coronary angiography. Here, PLA2G7 is linked to coronary artery disorder.